Skip to main content
Clinical Trials/CTRI/2024/10/074787
CTRI/2024/10/074787Not yet recruitingNot Applicable

Randomized controlled Clinical trial to evaluate the efficacy of Aargwadha Pratisarneeya Kshar in the management of Arsha (Second degree Internal Haemorrhoids).

Dr Kalyani Vilasrao Kale1 site in 1 country92 target enrollmentStarted: October 11, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
92
Locations
1
Primary Endpoint
Size of Arshankura (Haemorrhoids

Study Overview

Brief Summary

Main aim of ayurveda in to protect mankinds healthy life and to cure them from diseased conditions. A Change in lifestyle and dietary habits,such as consumption of fast food and spicy dishes can result in agnimandya and irregular bowel habits. One notable condition that arises from these factors is "ARSHA"a malady typically associated with adulthood and becoming more prevalant as one ages. The term "ARSHA" from thr root "RU-GATAU",with the addition of suffix ASUNA,signifying a threat to one’s well-being. This condition manifest as a protrusion of muscles that causes discomfort and can be likened to an adversary for patient.

Acharya Sushruta considered six types of arsha i.e. Vataj,Pittaj,Kaphaj,Raktaj,Sanipataj&Sahaj.

Haemorrhoids defined as dilated plexus of superior haemorrhoidal veins in relation to anal canal.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
16.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Diagnosed patients of Arsha with 2nd degree internal haemorrhoid will be taken for study.

Exclusion Criteria

  • Known case of 1st,3rd,4th degree haemorrhoids.
  • Patients having haemoglobin less than 8 gm%.
  • Known case of internal haemorrhoids associated withoter ano rectal disorderssuch as fistula-in-ano,fissure-in-ano.
  • Patients with bleeding disorder.

Outcomes

Primary Outcomes

Size of Arshankura (Haemorrhoids

Time Frame: baseline,7,14th day

before

Time Frame: baseline,7,14th day

and after the treatment.

Time Frame: baseline,7,14th day

Secondary Outcomes

  • 1. Constipation(2. Vedana (pain))

Investigators

Sponsor
Dr Kalyani Vilasrao Kale
Sponsor Class
Other [SELF sponsered]
Responsible Party
Principal Investigator
Principal Investigator

Dr.Kalyani Vilasrao Kale

MUHS Nashik.

Study Sites (1)

Loading locations...

Similar Trials